Parnax Lab Limited (BOM:506128)
India · Delayed Price · Currency is INR 137.20
-4.40 (-3.11%)
At close: Jul 28, 2026
Parnax Lab Market Cap
Parnax Lab has a market cap or net worth of 1.58 billion as of July 28, 2026. Its market cap has increased by 8.54% in one year.
Market Cap
1.58B
Enterprise Value
2.38B
Revenue
2.49B
Ranking
n/a
PE Ratio
13.36
Stock Price
137.20
ChartMarket Cap Chart
Since September 15, 2009, Parnax Lab's market cap has increased from 3.36M to 1.58B, an increase of 46,799.60%. That is a compound annual growth rate of 43.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.58B | 5.54% |
| Dec 31, 2025 | 1.49B | -22.62% |
| Dec 31, 2024 | 1.93B | 90.56% |
| Dec 29, 2023 | 1.01B | 21.10% |
| Dec 30, 2022 | 836.15M | 86.38% |
| Dec 31, 2021 | 448.63M | 86.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sat Kartar Life | 2.07B |
| Coral Laboratories | 1.99B |
| Kerala Ayurveda | 1.97B |
| Oxygenta Pharmaceutical | 1.93B |
| Sanjivani Paranteral | 1.85B |
| Accretion Pharmaceuticals | 1.83B |
| Bio Medica Laboratories | 1.74B |
| Speciality Medicines | 1.63B |